Related Experiment Video
Updated: Jul 7, 2026

Generation of Oligodendrocytes and Oligodendrocyte-Conditioned Medium for Co-Culture Experiments
Published on: February 9, 2020
Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS
Daniel Chesik1, Jacques De Keyser, Nadine Wilczak
1Department of Neurology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. d.chesik@med.umcg.nl
Abstract:
Amongst the many soluble extracellular factors stimulating intracellular signal transduction pathways and driving cellular processes such as proliferation, differentiation and survival, insulin-like growth factors (IGFs) stand out as indispensable factors for proper oligodendrocyte differentiation and accompanying myelin production. Owing to its potent myelinogenic capacity and its neuroprotective properties, IGFs hold therapeutic potential in demyelinating and neurodengenerative diseases. However, the IGF system is comprised of a complex molecular network involving regulatory binding proteins, proteases, cell surface and extracellular matrix components which orchestrate IGF-specific functions. Thus, the complexity by which these factors are tightly regulated makes a simplistic therapeutic approach towards treating demyelinating conditions unfeasible. In the present review, we address these issues and consider current therapeutic prospects of oligodendrocyte-targeted IGF-based therapies.
Insights
Insulin-like growth factors (IGFs) are crucial for myelin production and offer therapeutic potential for neurodegenerative diseases. However, their complex regulation presents challenges for developing effective oligodendrocyte-targeted therapies.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Soluble extracellular factors regulate crucial cellular processes like proliferation, differentiation, and survival.
- Insulin-like growth factors (IGFs) are vital for oligodendrocyte differentiation and myelin production.
- IGFs possess neuroprotective properties, indicating therapeutic potential for demyelinating and neurodegenerative diseases.
Purpose of the Study:
- To review the complex molecular network regulating the IGF system.
- To discuss the challenges in developing simplistic therapeutic approaches for demyelinating conditions.
- To explore current therapeutic prospects of oligodendrocyte-targeted IGF-based therapies.
Main Methods:
- Literature review of the IGF system and its role in myelination.
- Analysis of the regulatory components within the IGF network.
- Evaluation of therapeutic strategies for demyelinating diseases.
Main Results:
- The IGF system involves a complex interplay of binding proteins, proteases, and extracellular components.
- The intricate regulation of IGFs complicates straightforward therapeutic interventions.
- Oligodendrocyte-targeted IGF therapies show promise but require careful consideration of system complexity.
Conclusions:
- IGFs are essential for oligodendrocyte function and myelin repair.
- The complexity of the IGF system necessitates sophisticated therapeutic strategies.
- Further research into oligodendrocyte-targeted IGF therapies is warranted for neurological disorders.
More Related Videos
10:53Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
Published on: November 9, 2020
11:11Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
Published on: February 17, 2016
Related Concept Videos
Glial Cells
Neurogenesis and Regeneration of Nervous Tissue